Magnicor is effective and safe domestic drug for prophylaxis of cardiovascular diseases

Abstract

Data about pathogenetically justification of use, efficiency and safety of acetylsalicylic acid as antiplatelet agents in cardiology practice are analysed in the article. The article contains short analysis of the domestic market of acetylsalicylic acid preparations, that are used in cardiology practice. The article also contains recommendation of practical character for optimization of choice of acetylsalicylic acid preparations. The authors of the article pay great attention to the analysis of data about influence of medicinal form of acetylsalicylic acid preparations and composition of the combined preparations that contain it on pharmacokinetic parameters and profile of their safety. Based on these data the authors of the article come to the conclusion that one of the most safe and effective preparations of acetylsalicylic acid that is presented today at the market of Ukraine there is Magnicor.